SEATTLE — Half of American women 65 years old and older and more than 40% of those ages 50 to 64 experience some type of urinary incontinence. “It’s defined as the involuntary loss of urine and also, ...

Sacral neuromodulation, which is also called interstim, acts to provide a small amount of electrical stimulation to the nerves that run through the tailbone (sacrum) to the bladder. For reasons we do ...

The US Food and Drug Administration (FDA) has approved Medtronic’s Altaviva device, intended for the treatment of urge urinary incontinence. This implantable tibial neuromodulation (ITNM) device ...

Medtronic has received FDA approval for a new implant aimed at improving bladder control, with a small device placed near the ankle designed to be more convenient and accessible. Compared to other ...

An Israeli startup developing a neuromodulation device to treat urgency urinary incontinence certainly has the wind at its back these days. BlueWind Medical picked up $64 million in new financing to ...